Andrx replaces CEO
Executive Summary
Former Chesapeake Biological Labs CEO Thomas Rice replaces Richard Lane as Andrx' chief executive. Rice, who joined Andrx' board in April, says the change was "in no way associated with the company's finances, accounting or business conditions," but was aimed at accelerating implementation of strategic initiatives. Lane joined Andrx in June 2002 after leaving Bristol-Myers Squibb as part of a management change following disclosure of inventory problems (1"The Pink Sheet" May 27, 2002, p. 21)...